Luciano A. Marraffini

Luciano A. Marraffini

Auto-generated profile, based on publicly available information

Luciano A. Marraffini

Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
WJWenyan Jiang
Wenyan Jiang
DBDavid Bikard
David Bikard
DCDavid Cox
David Cox
FZFeng Zhang
Feng Zhang
LMLuciano A Marraffini
Luciano A Marraffini
A CRISPR-Cas system is harnessed to introduce template-driven mutations in S. pneumoniae and E. coli at high efficiency without requiring selectable markers. Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)–associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.

12 June 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DBDavid Bikard
David Bikard
WJWenyan Jiang
Wenyan Jiang
PSPoulami Samai
Poulami Samai
AHAnn Hochschild
Ann Hochschild
FZFeng Zhang
Feng Zhang
LMLuciano A. Marraffini
Luciano A. Marraffini
The ability to artificially control transcription is essential both to the study of gene function and to the construction of synthetic gene networks with desired properties. Cas9 is an RNA-guided double-stranded DNA nuclease that participates in the CRISPR-Cas immune defense against prokaryotic viruses. We describe the use of a Cas9 nuclease mutant that retains DNA-binding activity and can be engineered as a programmable transcription repressor by preventing the binding of the RNA polymerase (RNAP) to promoter sequences or as a transcription terminator by blocking the running RNAP. In addition, a fusion between the omega subunit of the RNAP and a Cas9 nuclease mutant directed to bind upstream promoter regions can achieve programmable transcription activation. The simple and efficient modulation of gene expression achieved by this technology is a useful asset for the study of gene networks and for the development of synthetic biology and biotechnological applications.

1 May 2015 in Cell
Verified
Journal Article
Closed access
PSPoulami Samai
Poulami Samai
NPNora Pyenson
Nora Pyenson
WJWenyan Jiang
Wenyan Jiang
GGGregory W. Goldberg
Gregory W. Goldberg
AHAsma Hatoum-Aslan
Asma Hatoum-Aslan
LMLuciano A. Marraffini
Luciano A. Marraffini

18 February 2015 in Nature
Verified
Journal Article
Open access
PDF file
RHRobert Heler
Robert Heler
PSPoulami Samai
Poulami Samai
JMJoshua W. Modell
Joshua W. Modell
CWCatherine Weiner
Catherine Weiner
GGGregory W. Goldberg
Gregory W. Goldberg
LMLuciano A. Marraffini
Luciano A. Marraffini
Clustered regularly interspaced short palindromic repeat (CRISPR) loci and their associated (Cas) proteins provide adaptive immunity against viral infection in prokaryotes. Upon infection, short phage sequences known as spacers integrate between CRISPR repeats and are transcribed into small RNA molecules that guide the Cas9 nuclease to the viral targets (protospacers). Streptococcus pyogenes Cas9 cleavage of the viral genome requires the presence of a 5′-NGG-3′ protospacer adjacent motif (PAM) sequence immediately downstream of the viral target. It is not known whether and how viral sequences flanked by the correct PAM are chosen as new spacers. Here we show that Cas9 selects functional spacers by recognizing their PAM during spacer acquisition. The replacement of cas9 with alleles that lack the PAM recognition motif or recognize an NGGNG PAM eliminated or changed PAM specificity during spacer acquisition, respectively. Cas9 associates with other proteins of the acquisition machinery (Cas1, Cas2 and Csn2), presumably to provide PAM-specificity to this process. These results establish a new function for Cas9 in the genesis of prokaryotic immunological memory.

31 August 2014 in Nature
Verified
Journal Article
Open access
PDF file
GGGregory W. Goldberg
Gregory W. Goldberg
WJWenyan Jiang
Wenyan Jiang
DBDavid Bikard
David Bikard
LMLuciano A. Marraffini
Luciano A. Marraffini
The Staphylococcus epidermidis CRISPR-Cas system can prevent lytic infection but tolerate lysogenization by temperate phage through a transcription-dependent DNA targeting mechanism. Temperate phages that integrate into the bacterial genome can carry genes that confer a fitness advantage. However, it has been unclear how this potential beneficial interaction is balanced against host defence by CRISPR-Cas immune systems, which defend bacteria against phage infection using Cas nucleases and small RNA guides that provide sequence specificity for cleavage of target sites in the phage genome. Here Luciano Marraffini and colleagues show that the Staphylococcus epidermidis CRISPR-Cas system can prevent lytic phage infection but tolerate lysogenization by temperate phage through a transcription-dependent DNA targeting mechanism. This work expands the repertoire of CRISPR-based immune functions to include a facility for conditional tolerance of foreign elements. A fundamental feature of immune systems is the ability to distinguish pathogenic from self and commensal elements, and to attack the former but tolerate the latter1. Prokaryotic CRISPR-Cas immune systems defend against phage infection by using Cas nucleases and small RNA guides that specify one or more target sites for cleavage of the viral genome2,3. Temperate phages include viruses that can integrate into the bacterial chromosome, and they can carry genes that provide a fitness advantage to the lysogenic host4,5. However, CRISPR-Cas targeting that relies strictly on DNA sequence recognition provides indiscriminate immunity both to lytic and lysogenic infection by temperate phages6—compromising the genetic stability of these potentially beneficial elements altogether. Here we show that the Staphylococcus epidermidis CRISPR-Cas system can prevent lytic infection but tolerate lysogenization by temperate phages. Conditional tolerance is achieved through transcription-dependent DNA targeting, and ensures that targeting is resumed upon induction of the prophage lytic cycle. Our results provide evidence for the functional divergence of CRISPR-Cas systems and highlight the importance of targeting mechanism diversity. In addition, they extend the concept of ‘tolerance to non-self’ to the prokaryotic branch of adaptive immunity.

29 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
AMAlexander J. Meeske
Alexander J. Meeske
SNSandra Nakandakari-Higa
Sandra Nakandakari-Higa
LMLuciano A. Marraffini
Luciano A. Marraffini